Analysis of the polymorphic (GT)(n) repeat at the dopamine β- hydroxylase gene in Spanish patients affected by schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 96, Issue 1, 2000, Pages 88-92

  Arrufat, Francisco J ^a   Diaz, Ramón ^b   Queralt, Rosa ^b   Navarro, Victor ^b   Marcos, Teodoro ^b   Massana, Guillem ^b   Massana, Joan ^b   Ballesta, Francisca ^b   Oliva, Rafael ^b  

^a Servicio de Oncología Médica   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Catecholamine; Dopamine hydroxylase; Microsatellite; Polymorphic (GT)(n) repeat; Schizophrenia

Indexed keywords

CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; MICROSATELLITE DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA DETERMINATION; GENE FREQUENCY; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SPAIN;

ALLELES; BASE SEQUENCE; DINUCLEOTIDE REPEATS; DNA PRIMERS; DOPAMINE BETA-HYDROXYLASE; GENE FREQUENCY; HUMANS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; SPAIN;

EID: 0034615030     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000207)96:1<88::AID-AJMG18>3.0.CO;2-V     Document Type: Article

References (36)

1. Arndt S, Alliger RJ, Andreasen NG. 1991. The distinction of positive and negative symptoms. Br J Psychiatry 158:317-322.
2. Bassam BJ, Caetano-Anollés G, Gresshoff PM. 1991. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196:80-83.
3. Bleuler E. 1911. Dementia praecox or the group of schizophrenia, trans. J Zinkin. New York: International Universities Press.
4. Carpenter WT, Heinrichs DW, Wagman AMI. 1985. On the heterogeneity of schizophrenia. In: Alpert M, editor. Controversies in schizophrenia. New York: Guilford Press. p 25-37.
5. Cohen R, Brost U. 1987. Psychological models of schizophrenic impairments. In: Häfner H, Gattaz WF, Janzarik W, editors. Search for the causes of schizophrenia. Berlin: Springer-Verlag. p 189-219.
6. Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hilsdale (NJ) Lawrence Erlbaum. p. 215-271
7. Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig IW. 1988. Localization of the human dopamine-beta-hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 48:48-50.
8. Cubells JF, Kobayashi K, Nagatsu T, et al. 1997. Population genetics of a functional variant of the dopamine beta-hydroxylase gene. Am J Med Genet 74:374-379.
9. Endicott J, Spitzer RL. 1978. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-844.
10. Garver DL, Reich T, Isenberg KE, Cloninger CR. 1989. Schizophrenia and the question of genetic heterogeneity. Schizophr Bull 15:421-430.
11. Goate A, Chartier-Harlin MC, Mullan M, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
12. Gottesman II, Shields J. 1982. Schizophrenia - the epigenetic puzzle. Cambridge University Press.
13. Hornykiewicz O. 1982. Brain catecholamines in schizophrenia - a good case for noradrenaline. Nature 299:484-486.
14. Klimidis S, Stuart GW, Minas IH, Copolov DL, Singh BS. 1993. Positive and negative symptoms in the psychoses. Re-analysis of published and SANS global ratings. Schizophr Res 9:11-18.
15. Leonhard K. 1980. Contradictory issues in the origin of schizophrenia. Br J Psychiatry 136:437-444.
16. Matthysse S. 1978. Etiological diversity in the psychoses. In Morton NM, Chung CS, editors. Genetic epidemiology. New York: Academic Press. p 311-328.
17. Matthysse S, Sugarman J. 1978. Neurotransmitters of schizophrenia. In Iversen SD, Snyder SH, editors. Handbook of psychopharmacology, vol. 10. New York: Plenum. p 211-242.
18. Meszaros K, Lenzinger E, Füreder T, et al. 1996. Schizophrenia and the dopamine-β-hydroxylase gene: results of a linkage and association study. Psychiatr Genet 6:17-22.
19. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215.
20. Nahmias J, Burles MW, Povey S, Porter C, Craig I, Wolfe J. 1992. A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine β-hydroxylase locus. Hum Mol Genet 1:286.
21. Oliva R, Tolosa E, Ezquerra M, et al. 1998. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch Neurol 55:1122-1124.
22. Peralta V, de leon J, Cuesta MJ. 1992. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br J Psychiatry 61:335-343.
23. Porter CJ, Nahmias J, Wolfe J, Craig IW. 1992. Dinucleotide repeat polymorphism at the human dopamine β-hydroxylase (DBH) locus. Nucleic Acids Res 20:1429.
24. Schellenberg GD, Bird TD, Wijsman EM, et al. 1992. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258:668-671.
25. Seeman P. 1980. Brain dopamine receptors. Pharmacol Rev 32:229-313.
26. Silver H, David D, Kaplan M, et al. 1993. Factor analysis of schizophrenic symptoms and comparison of different rating scales. Schizophr Res 10:67-75.
27. Slater E. 1947. Genetical causes of schizophrenic symptoms. Monatschr Psychiatr Neurol 113:50-59.
28. Stein L, Wise CD. 1971. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hyroxydopamine. Science 171:1032-1036.
29. Terwilliger J, Ott J. 1992. A haplotype-based "haplotype relative risk" approach to detecting allelic associations. Hum Hered 42:337-346.
30. Tsuang MT, Bucher KD, Fleming JA. 1982. Testing the monogenic theory of schizophrenia: an application of segregation analysis to blind family study data. Br J Psychiatry 140:595-599.
31. Tsuang MT, Lyons MJ, Faraone SV. 1990. Heterogeneity of schizophrenia. Conceptual models and analytic strategies. Br J Psychiatry 156:17-26.
32. Vionnet N, Stoffel M, Taheda J, et al. 1992. Nonsense mutation in the glucokinase gene causes early onset non-insulin dependent diabetes. Nature 356:721-722.
33. Wei J, Ramchand CN, Clark AE, Hemmings GP. 1996a. A study of enzymes involved in catecholamine metabolism in parents of patients with schizophrenia. Schizophr Res 19:27-32.
34. Wei J, Ramchand CN, Hemmings GP. 1996b. A study of the relationship between the DBH activity in serum and MspI polymorphic site in intron 9 of the human DBH gene in schizophrenia. Schizophr Res 22:77-80.
35. Wei J, Xu HM, Ramchand CN, Hemmings GP. 1997a. Is the polymorphic microsatellite of the dopamine β-hydroxylase gene associated with biochemical variability of the catecholamine pathway in schizophrenia? Biol Psychiatry 41:762-767.
36. n repeat at its gene locus in healthy individuals. Hum Genet 99:52-55.